The hardware and bandwidth for this mirror is donated by METANET, the Webhosting and Full Service-Cloud Provider.
If you wish to report a bug, or if you are interested in having us mirror your free-software or open-source project, please feel free to contact us at mirror[@]metanet.ch.
Chooses subgroup specific optimal doses in a phase I dose finding clinical trial allowing for subgroup combination and simulates clinical trials under the subgroup specific time to event continual reassessment method. Chapple, A.G., Thall, P.F. (2018) <doi:10.1002/pst.1891>.
| Version: | 4.0.5 |
| Imports: | Rcpp (≥ 0.12.18) |
| LinkingTo: | Rcpp, RcppArmadillo |
| Published: | 2021-09-15 |
| DOI: | 10.32614/CRAN.package.SubTite |
| Author: | Andrew Chapple |
| Maintainer: | Andrew Chapple <achapp at lsuhsc.edu> |
| License: | GPL-2 |
| NeedsCompilation: | yes |
| CRAN checks: | SubTite results |
| Reference manual: | SubTite.pdf |
| Package source: | SubTite_4.0.5.tar.gz |
| Windows binaries: | r-devel: SubTite_4.0.5.zip, r-release: SubTite_4.0.5.zip, r-oldrel: SubTite_4.0.5.zip |
| macOS binaries: | r-release (arm64): SubTite_4.0.5.tgz, r-oldrel (arm64): SubTite_4.0.5.tgz, r-release (x86_64): SubTite_4.0.5.tgz, r-oldrel (x86_64): SubTite_4.0.5.tgz |
| Old sources: | SubTite archive |
Please use the canonical form https://CRAN.R-project.org/package=SubTite to link to this page.
These binaries (installable software) and packages are in development.
They may not be fully stable and should be used with caution. We make no claims about them.